A compound from a fungus can protect brain cells from damage caused by too much glutamate, a brain chemical, by calming down harmful signals inside the cells.
Claim Context
Fischerin (153), a polyketide from Neosartorya fischeri, protects mouse hippocampal neuronal (HT22) cells from glutamate-induced cell death in vitro by reducing intracellular reactive oxygen species and calcium levels, and by inhibiting sustained phosphorylation of MAPK pathways (ERK, JNK, p38), suggesting neuroprotective mechanisms.
“Fischerin (153) ... was able to significantly recover the viability of mouse hippocampal neuronal (HT22) cells decreased by glutamate. Compound 153 also decreased a glutamate-induced increase in intracellular reactive oxygen species (ROS) and Ca+ concentration ... the phosphorylation of...”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether fischerin improves neurological outcomes in human neurodegenerative diseases
A double-blind, placebo-controlled Phase II RCT with 120 patients with early Alzheimer's disease, randomized to oral fischerin (100 mg daily) or placebo for 18 months, measuring cognitive decline (ADAS-Cog), brain atrophy (MRI), and biomarkers (CSF Aβ, tau)
Whether fischerin use is associated with slower cognitive decline
A prospective cohort study following 500 older adults with mild cognitive impairment, tracking those who consume fungal-derived supplements containing fischerin analogs, assessing cognitive trajectories over 5 years
Whether prior use of fungal neuroprotective compounds is associated with lower risk of dementia
A matched case-control study of 400 dementia patients versus 400 controls, assessing lifetime exposure to fungi-rich environments or dietary fungal products
The prevalence of neuroprotective effects in different neuronal cell models treated with fischerin
A cross-sectional study testing fischerin in 10 different in vitro models of neurotoxicity (e.g., amyloid-beta, rotenone, MPTP) across multiple laboratories, measuring cell viability and oxidative stress markers